Page 35 - Viral Vector News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Viral Vector Market is Flourishing Globally, Key Players -BioReliance Richter-Helm UniQure

Nkarta and Sana Biotechnology have each leased space in California to support their cell therapy manufacturing plans.

In the three months since Johnson & Johnson's COVID-19 vaccine received emergency use authorization from the U.S. Food and Drug Administration, more than 10 million Americans have received the vaccine, according to the Centers for Disease Control and Prevention.

Viral Vector & Plasmid DNA Manufacturing Market Research Report by Type (Adeno-Associated Virus, Adenovirus, and Lentivirus), by Indication (Cancer, Genetic Disorder, and Infectious Disease), by Workflow, by Application, by End User, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19New York, June 10, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Viral Vector & Plasmid DNA Manufacturing M

Major players in the gene therapy market are Novartis AG, Bluebird Bio, Inc. , Spark Therapeutics, Inc. , Audentes Therapeutics, Voyager Therapeutics, Applied Genetic Technologies Corporation, UniQure N.New York, June 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Gene Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030" - https://www.reportlinker.com/p06090625/?utm_source=GNW V., Celgene Corporation, Cellectis S.A., and Sangamo Therapeutics.